MedPath

Application of laser assisted anti-infection therapy for the gum disease around dental implants

Phase 3
Conditions
Z96.5, K05
Peri-implant disease.
Presence of tooth-root and mandibular implants, Gingivitis and periodontal diseases
Registration Number
IRCT201609281248N3
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
25
Inclusion Criteria

•Age=18 yr.
•Persistence of at least ONE implant with at least ONE year
•Persistence of Peri- implant disease

Exclusion Criteria

•Using antibiotic from 3 months prior to study
•Using NSAIDS and/or corticosteroids on resent 3 mounts,
•Presence of any history of any treatment for Peri- implant disease during last 3 mounts
• Being a current and/or former smokers , drug or alcohol abuser
•Using Bisphosphonates, Cyclosporine, Coumadin, Warfarin and Heparin
•Pregnancy and lactation
•Presence of an active periodontal disease after therapy
•Presence of poorly controlled diabetes and other debilitating diseases
•Refraining of consent signature

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding on Probing. Timepoint: 2 weeks, 2 mounths. Method of measurement: Clinical Examination.
Secondary Outcome Measures
NameTimeMethod
Interleukin 1. Timepoint: baseline, 2 weeks, 2 months. Method of measurement: Labratoary exam.;Probing Depth. Timepoint: baseline, 2 weeks, 2 months. Method of measurement: clinical examination.;Clinical attachment level. Timepoint: baseline, 2 weeks, 2 months. Method of measurement: clinical examination.;Pain on probing. Timepoint: baseline, 2 weeks, 2 months. Method of measurement: clinical examination.;Interleukin 6. Timepoint: baseline, 2 weeks, 2 months. Method of measurement: Labratoary exam.;TNF alpha. Timepoint: baseline, 2 weeks, 2 months. Method of measurement: Labratoary exam.
© Copyright 2025. All Rights Reserved by MedPath